| Authors: |
Cherry JJ; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., DiDonato CJ; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Human Molecular Genetics Program, Ann & Robert Lurie Children's Hospital, Stanley Manne Research Institute, Chicago, Illinois, United States of America., Androphy EJ; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America., Calo A; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Potter K; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Human Molecular Genetics Program, Ann & Robert Lurie Children's Hospital, Stanley Manne Research Institute, Chicago, Illinois, United States of America., Custer SK; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America., Du S; Precision Medicine, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Foley TL; Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America.; Primary Pharmacology Group, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America., Gopalsamy A; Medicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Reedich EJ; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Human Molecular Genetics Program, Ann & Robert Lurie Children's Hospital, Stanley Manne Research Institute, Chicago, Illinois, United States of America., Gordo SM; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Gordon W; Precision Medicine, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Hosea N; Pharmacokinetics and Drug Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Jones LH; Medicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Krizay DK; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., LaRosa G; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Li H; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America., Mathur S; Business Technology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Menard CA; Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America.; Primary Pharmacology Group, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America., Patel P; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Ramos-Zayas R; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Rietz A; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America., Rong H; Pharmacokinetics and Drug Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Zhang B; Clinical Genetics, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America., Tones MA; Rare Disease Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America. |
